Cargando…

Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study

PURPOSE: The future of non-operative management of DCIS relies on distinguishing lesions requiring treatment from those needing only active surveillance. More accurate preoperative staging and grading of DCIS would be helpful. We identified determinants of upstaging preoperative breast biopsies show...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mannu, Gurdeep S., Groen, Emma J., Wang, Zhe, Schaapveld, Michael, Lips, Esther H., Chung, Monica, Joore, Ires, van Leeuwen, Flora E., Teertstra, Hendrik J., Winter-Warnars, Gonneke A. O., Darby, Sarah C., Wesseling, Jelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2019
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6797705/ https://www.ncbi.nlm.nih.gov/pubmed/31388937 http://dx.doi.org/10.1007/s10549-019-05362-1

Ejemplares similares

Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
por: Elshof, Lotte E., et al.
Publicado: (2016)

Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer
por: Groen, Emma J., et al.
Publicado: (2021)

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ
por: Elshof, Lotte E., et al.
Publicado: (2018)

The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study
por: Elshof, Lotte E., et al.
Publicado: (2017)

Treating (low-risk) DCIS patients: What can we learn from real-world cancer registry evidence?
por: Byng, Danalyn, et al.
Publicado: (2021)

Variability in grading of ductal carcinoma in situ among an international group of pathologists
por: van Seijen, Maartje, et al.
Publicado: (2021)

A Nationwide Cross-Sectional Survey of UK Breast Surgeons' Views on the Management of Ductal Carcinoma In Situ
por: Mannu, Gurdeep S., et al.
Publicado: (2015)

Invasive breast cancer and breast cancer mortality after ductal carcinoma in situ in women attending for breast screening in England, 1988-2014: population based observational cohort study
por: Mannu, Gurdeep S, et al.
Publicado: (2020)

Ductal carcinoma in situ: to treat or not to treat, that is the question
por: van Seijen, Maartje, et al.
Publicado: (2019)

Patterns of treatment and outcome of ductal carcinoma in situ in the Netherlands
por: Luiten, Jacky D., et al.
Publicado: (2021)

Breast adipocyte size associates with ipsilateral invasive breast cancer risk after ductal carcinoma in situ
por: Almekinders, Mathilde M. M., et al.
Publicado: (2021)

Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast
por: van Seijen, Maartje, et al.
Publicado: (2021)

Ductal carcinoma in situ of the breast, a population-based study of epidemiology and pathology
por: Kricker, A, et al.
Publicado: (2004)

Cardiovascular Morbidity and Mortality After Treatment for Ductal Carcinoma In Situ of the Breast
por: Boekel, Naomi B., et al.
Publicado: (2014)

Prognostic value of histopathological DCIS features in a large-scale international interrater reliability study
por: Groen, Emma J., et al.
Publicado: (2020)

The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands
por: Schaapveld, Michael, et al.
Publicado: (2007)

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study
por: Doebar, Shusma C., et al.
Publicado: (2016)

Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center
por: Nicosia, Luca, et al.
Publicado: (2022)

Contralateral breast cancer risk in patients with ductal carcinoma in situ and invasive breast cancer
por: Giardiello, Daniele, et al.
Publicado: (2020)

Simplifying Breast Imaging Reporting and Data System classification of mammograms with pure suspicious calcifications
por: Menezes, Gisela LG, et al.
Publicado: (2017)

High burden of subsequent malignant neoplasms and cardiovascular disease in long-term Hodgkin lymphoma survivors
por: de Vries, Simone, et al.
Publicado: (2018)

Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands
por: van Dooijeweert, Carmen, et al.
Publicado: (2018)

Prognostic value of breast MRI characteristics before and during neoadjuvant endocrine therapy in patients with ER+/HER2- breast cancer
por: Ragusi, Max AA, et al.
Publicado: (2021)

Molecular markers of risk of subsequent invasive breast cancer in women with ductal carcinoma in situ: protocol for a population-based cohort study
por: Rohan, Thomas E, et al.
Publicado: (2021)

Factors influencing the initiation of adjuvant endocrine therapy in patients with estrogen receptor-positive ductal carcinoma in situ: a single institution experience
por: Levy, Julia, et al.
Publicado: (2022)

Employment and social benefits up to 10 years after breast cancer diagnosis: a population-based study
por: Paalman, C H, et al.
Publicado: (2016)

Retinal phototransduction
por: Mannu, Gurdeep S.
Publicado: (2014)

Pathological and Biological Differences Between Screen-Detected and Interval Ductal Carcinoma in situ of the Breast
por: de Roos, Marnix A., et al.
Publicado: (2007)

Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast
por: Chen, A C, et al.
Publicado: (2014)

Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival
por: Morales-Oyarvide, Vicente, et al.
Publicado: (2017)

Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers
por: Lobbes, Marc B.I., et al.
Publicado: (2017)

Breslow thickness in the Netherlands: a population-based study of 40 880 patients comparing young and elderly patients
por: Kruijff, S, et al.
Publicado: (2012)

An interesting rash: leucocytoclastic vasculitis with type 2 cryoglobulinaemia
por: Mannu, Gurdeep Singh
Publicado: (2010)

Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
por: Takada, Koji, et al.
Publicado: (2020)

Risk and prognostic significance of metachronous contralateral testicular germ cell tumours
por: Schaapveld, M, et al.
Publicado: (2012)

Cohort profile: Risk and risk factors for female breast cancer after treatment for childhood and adolescent cancer: an internationally pooled cohort
por: Wang, Yuehan, et al.
Publicado: (2022)

Management of Pruritus in Chronic Liver Disease
por: Bhalerao, Angeline, et al.
Publicado: (2015)

Making progress in early breast cancer: Taking time or accepting risk?
por: Mannu, Gurdeep S., et al.
Publicado: (2017)

Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors
por: Truin, Wilfred, et al.
Publicado: (2017)

Diagnostic value of radiomics and machine learning with dynamic contrast-enhanced magnetic resonance imaging for patients with atypical ductal hyperplasia in predicting malignant upgrade
por: Lo Gullo, Roberto, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jnt8bbgcgkpd94tlqata60nf6i